Adairs (ASX:ADH) shares have continued recent momentum with a 38% gain in the last month alone. The full year gain of 47% is pretty reasonable, too. Assuming no other changes, a sharply higher share ...

Adairs Limited (ASX:ADH), is not the largest company out there, but it led the ASX gainers with a relatively large price hike in the past couple of weeks. While good news for shareholders, the company ...

Diabetes insipidus occurs when problems with antidiuretic hormone (ADH) cause the body to remove too much water. A synthetic version of ADH can help restore a person’s levels and treat some types of ...

In July 2018, Adairs Limited (ASX:ADH) released its latest earnings announcement, which signalled that the business benefited from a robust tailwind, eventuating to a double-digit earnings growth of ...

Adairs Limited (ASX:ADH) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of ADH, it is a ...

Investors who want to cash in on Adairs Limited’s (ASX:ADH) upcoming dividend of AU$0.08 per share have only 4 days left to buy the shares before its ex-dividend date, 11 September 2018, in time for ...

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a condition in which there are high amounts of antidiuretic hormone (ADH) released from the pituitary gland or other sources. SIADH ...

Syndrome of Inappropriate Anti-Diuretic Hormone secretion, or SIADH, is a known complication of small-cell lung cancer (SCLC). SIADH makes your body produce too much of a hormone that causes your ...

Nephrogenic diabetes insipidus is a long name for an uncommon condition. Nephrogenic diabetes insipidus is not the same as diabetes mellitus. Diabetes mellitus causes elevated blood sugar levels. But ...

Adairs Limited (ASX:ADH), is not the largest company out there, but it saw a decent share price growth of 13% on the ASX over the last few months. The recent rally in share prices has nudged the ...